Anxiety and Depression
Anxiety and depression are among the most common mental health disorders, affecting millions of individuals worldwide. Although traditional therapies, including medication and psychotherapy, can be effective, there is a constant search for additional therapeutic options. Mild Hyperbaric Oxygen Therapy (mHBOT) is an emerging treatment with potential benefits for those dealing with anxiety and depression.
What is Mild Hyperbaric Oxygen Therapy?
mHBOT is a non-invasive treatment where individuals breathe oxygen at a pressure higher than atmospheric pressure, usually between 1.3 to 1.5 times greater [1]. This higher oxygen concentration aims to stimulate the healing process in the body and has been used for various medical conditions.
Potential Benefits of mHBOT for Anxiety and Depression
Enhanced Brain Function
mHBOT can improve brain function by increasing the amount of oxygen delivered to the brain. This increased oxygen can promote the healing of damaged neurons and stimulate the creation of new blood vessels, which may lead to improved mood and cognition [2].
Neuroplasticity Enhancement
Neuroplasticity, the brain's ability to adapt and change, is considered a fundamental aspect of healing from mental health issues like anxiety and depression. Research indicates that mHBOT can enhance neuroplasticity, potentially leading to long-term improvements in these conditions [3].
Reduction in Inflammation
Recent research suggests a link between inflammation and depression. As mHBOT has been shown to reduce inflammation, it might help alleviate symptoms of depression and anxiety [4].
Increased production of Serotonin
mHBOT has been suggested to increase the production of serotonin [5], a neurotransmitter that plays a crucial role in mood regulation. Low levels of serotonin are often linked to depression, thus increasing its production could potentially alleviate depressive symptoms.
Moving Forward with mHBOT for Anxiety and Depression
While promising, it's crucial to remember that the research on mHBOT and its effect on anxiety and depression is still in its early stages. More large-scale studies are needed to fully understand and validate the impact of mHBOT on these mental health conditions.
As research progresses, mHBOT may emerge as a valuable adjunctive therapy for anxiety and depression. Individuals considering mHBOT should consult with a healthcare provider to discuss its benefits and potential risks.
In summary, while the scientific community awaits more robust evidence to fully endorse mHBOT for anxiety and depression, the potential benefits are promising and merit further exploration.
References:
Harch, P.G., Andrews, S.R., Fogarty, E.F. et al. (2012). A phase I study of low-pressure hyperbaric oxygen therapy for blast-induced post-concussion syndrome and post-traumatic stress disorder. J Neurotrauma 29, 168–185 ↩
Al-Waili, N.S., Butler, G.J., Beale, J., Abdullah, M.S., Finkelstein, M., Merrow, M., Rivera, R., Petrillo, R.L., Carrey, Z., Lee, B.Y. (2005). Hyperbaric oxygen in the treatment of patients with cerebral stroke, brain trauma, and neurologic disease. Adv Ther, 22(6), 659-78 ↩
Zhang, K., Wang, L., Wang, H., Wang, W. (2018). Hyperbaric Oxygen Therapy Promotes Neurogenesis: Where Do We Stand? Med Gas Res, 8(2), 72-78 ↩
Thom, S.R. (2009). Hyperbaric oxygen: Its mechanisms and efficacy. Plastic and reconstructive surgery, 127(Suppl 1), 131S-141S ↩
Amen, D.G., Taylor, D.V., Ojala, K., Kaur, J., Willeumier, K. (2017). Effects of brain-directed nutrients on cerebral blood flow and neuropsychological testing: A randomized, double-blind, placebo-controlled, crossover trial. Adv Mind Body Med, 31(2), 4-13 ↩